Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 49 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 102 | 5,736−6.4%/yr | −6.4%/yr | 7.31.0× | 5% | 5,320 in 2030−1.2%/yr |
| Tumor & fibroid embolization |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 7 |
| 565+12%/yr |
| +12%/yr |
| 0.71.4× |
| 78% |
| 1,300 in 2030+15%/yr |
| Tumor ablation | 0 | 228−3.3%/yr | −3.3%/yr | 0.30.8× | 0% | 370 in 2030+8.4%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.